Viking Therapeutics (VKTX) Amortizatization of Intangibles (2014 - 2026)

Viking Therapeutics has disclosed Amortizatization of Intangibles across 13 years of filings, most recently posting $85000.0 for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $85000.0, down 23.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.3 million (down 46.5% YoY), and the FY2025 annual result was $9.3 million, down 46.23% from the prior year.
• Amortizatization of Intangibles came in at $85000.0 for Q1 2026 at Viking Therapeutics, down from $8.9 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $17.0 million in Q4 2024 to a low of -$8.0 million in Q3 2024.
• The 5-year median for Amortizatization of Intangibles is $85000.0 (2026), against an average of $1.5 million.
• Across the five-year window, Amortizatization of Intangibles slumped 1030.56% in 2022 and surged 22914.86% in 2024, its largest moves.
• Viking Therapeutics' Amortizatization of Intangibles stood at -$1.4 million in 2022, then jumped by 105.15% to $74000.0 in 2023, then soared by 22914.86% to $17.0 million in 2024, then slumped by 47.47% to $8.9 million in 2025, then sank by 99.05% to $85000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $85000.0 (Q1 2026), $8.9 million (Q4 2025), and $114000.0 (Q3 2025), per Business Quant data.